# Dosing Obese With Noxafil® Under a Trial (DONUT)

> **NCT03246386** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Morbid Obesity

## Interventions

- **DRUG:** Posaconazole Injection [Noxafil] 300mg
- **DRUG:** Posaconazole Injection [Noxafil] 400mg

## Key facts

- **NCT ID:** NCT03246386
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-05
- **Primary completion:** 2018-09-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246386, "Dosing Obese With Noxafil® Under a Trial (DONUT)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03246386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*